Quest Diagnostics Incorporated ( DGX) - Stock Earnings
DGX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 245.0 million USD | 2.8 billion USD |
| 2025Q4 | 245.0 million USD | 2.8 billion USD |
| 2026Q1 | 252.0 million USD | 2.9 billion USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
DGX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 854.0 million USD | 9.3 billion USD |
| 2024 | 871.0 million USD | 9.9 billion USD |
| 2025 | 992.0 million USD | 11.0 billion USD |
| 2026 Est. | — | — |
DGX
List: Contenders
Price: $193.67
Dividend Yield: 1.69%
Forward Dividend Yield: 1.78%
Payout Ratio: 40.49%
Dividend Per Share: 3.44 USD
Earnings Per Share: 9.00 USD
P/E Ratio: 21.28
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 1.3 million
Ebitda: 346.0 millionMarket Capitalization: 21.2 billion
Average Dividend Frequency: 4
Years Paying Dividends: 23
DGR3: 8.27%
DGR5: 8.27%
DGR10: 9.60%
DGR20: 13.64%